Eculizumab is a first-in-class recombinant humanized monoclonal antibody targeting complement protein C5. C5, which can only recognize humans, cannot bind to C5 of other species.
Molecular Weight:
148000
Purity:
>98%
CAS Number:
[219685-50-4]
Target:
Complement System
* VAT and and shipping costs not included. Errors and price changes excepted
